News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306 Results
Type
Article (23)
Press Release (283)
Section
Business (106)
Deals (11)
Drug Development (76)
FDA (4)
Job Trends (3)
News (190)
Policy (16)
Tag
Academia (2)
Alliances (21)
Antibody-drug conjugate (ADC) (1)
Approvals (4)
Best Places to Work (3)
Cancer (4)
CAR-T (1)
Cell therapy (1)
Clinical research (53)
COVID-19 (1)
Data (1)
Diagnostics (2)
Earnings (57)
Events (55)
FDA (4)
GLP-1 (2)
Government (2)
Healthcare (5)
Infectious disease (1)
IPO (9)
Legal (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (2)
NextGen Class of 2024 (1)
Pancreatic cancer (1)
People (29)
Phase I (32)
Phase II (17)
Phase III (18)
Pipeline (1)
Preclinical (14)
Regulatory (15)
Research institute (5)
United States (8)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (25)
2024 (23)
2023 (31)
2022 (48)
2021 (43)
2020 (32)
2019 (19)
2018 (14)
2017 (22)
2016 (17)
2015 (7)
2014 (12)
2013 (18)
2012 (6)
2011 (2)
2010 (1)
Location
Asia (15)
Europe (261)
Massachusetts (7)
North Carolina (1)
306 Results for "nanobiotix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
December 18, 2024
·
5 min read
Genetown
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
NANOBIOTIX announced today that Company management will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference. Please see below for details of the event.
May 23, 2024
·
3 min read
Press Releases
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
December 10, 2024
·
7 min read
Business
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
NANOBIOTIX provided an update on operational progress and reported financial results for the first quarter of 2024.
May 22, 2024
·
4 min read
Press Releases
NANOBIOTIX to Participate in Multiple Investor Conferences in November 2024
October 31, 2024
·
2 min read
Press Releases
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
November 12, 2024
·
8 min read
Business
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
NANOBIOTIX announced that it will report its financial and operational results for the first quarter of 2024 on May 22, 2024, before the US and EU markets open.
May 15, 2024
·
2 min read
Genetown
Nanobiotix to Present at Upcoming Investor Conferences in March 2024
NANOBIOTIX announced that Company management will participate in fireside chats at the upcoming Guggenheim Healthy Altitudes Summit and the Leerink Partners Global Biopharma Conference.
March 6, 2024
·
2 min read
Genetown
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
NANOBIOTIX announced updates to its corporate strategy designed to enable long-term growth in view of significant progress in the Company’s collaboration for the co-development and global commercialization of lead therapeutic candidate NBTXR3.
May 21, 2024
·
17 min read
Business
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
NANOBIOTIX announced that it will report its financial and operational results for the fourth quarter and full year ended December 31, 2023, on Wednesday, April 24, 2024, after the close of the US market.
April 17, 2024
·
2 min read
1 of 31
Next
